Drugs / CVX-045
last change Nov 2010 re-read 3 minutes ago

CVX-045

Developed for
carcinoma
Investigated by
Pfizer

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00879554 Feb 2007 → Mar 2009 carcinoma Pfizer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CVX-045 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00879554 ↗
Route Intravenous “Weekly, intravenous dose” NCT00879554 ↗